The use of direct ultraviolet irradiation and cyclosporine in facilitating indefinite pancreatic islet allograft acceptance

Henry Lau, Keith Reemtsma, Mark A. Hardy

Research output: Contribution to journalArticle

Abstract

We have previously shown that direct ultraviolet (UV) irradiation of islets can reduce their immunogenicity without alteration of their endocrine function and effect prolonged survival of islet allografts in the Lewis-to-ACI strain combination without the use of immuno-suppression. This study extends that work to investigate the survival of UV-irradiated Wistar-Furth islets instreptozotocin-diabetic Lewis rats, in which case the recipient is a relatively “high responder” to W/F alloantigens. Lewis recipients of 24-hr cultured W/F isletsuniformly rejected islet allografts within one week of transplantation while the additional immunosuppression with cyclosporine (CsA) at 15 or 30 mg/kg on days 0, +1, and +2 was ineffective in prolonging islet allograft survival. Wistar-Furth islets, which were UV-irradiated at 850–900 J/m2 and cultured for 24 hr prior to transplantation, did not survive any longer than those in control animals receiving untreated islets (MST 5.5 + 1 day). When UV irradiation of islets was combined with recipient peritransplant treatment with CsA at 15 mg/kg on days 0,+1, and +2 islet allograft survival was markedly prolonged (MST of 18 + 4.1 days). Treatment of diabetic recipients of UV irradiated islets with an increased dose of CsA (30 mg/kg) during the same peritransplant period (0, +1, +2 days) resulted in 100% islet allograft survival beyond 120 days. This data demonstrate the effectiveness and synergism between the use of the pretransplant UV irradiation of islet allograft and the peritransplant immunosuppression of the recipient with CsA in inducing prolonged islet allograft survival in “high responder” recipients, in which the singular use of either modality may be ineffective.

Original languageEnglish (US)
Pages (from-to)566-569
Number of pages4
JournalTransplantation
Volume38
Issue number6
StatePublished - 1984
Externally publishedYes

Fingerprint

Islets of Langerhans
Cyclosporine
Allografts
Immunosuppression
Transplantation
Isoantigens
Therapeutics

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

The use of direct ultraviolet irradiation and cyclosporine in facilitating indefinite pancreatic islet allograft acceptance. / Lau, Henry; Reemtsma, Keith; Hardy, Mark A.

In: Transplantation, Vol. 38, No. 6, 1984, p. 566-569.

Research output: Contribution to journalArticle

@article{c0c9f8375ae0406480ba47fac78b41e2,
title = "The use of direct ultraviolet irradiation and cyclosporine in facilitating indefinite pancreatic islet allograft acceptance",
abstract = "We have previously shown that direct ultraviolet (UV) irradiation of islets can reduce their immunogenicity without alteration of their endocrine function and effect prolonged survival of islet allografts in the Lewis-to-ACI strain combination without the use of immuno-suppression. This study extends that work to investigate the survival of UV-irradiated Wistar-Furth islets instreptozotocin-diabetic Lewis rats, in which case the recipient is a relatively “high responder” to W/F alloantigens. Lewis recipients of 24-hr cultured W/F isletsuniformly rejected islet allografts within one week of transplantation while the additional immunosuppression with cyclosporine (CsA) at 15 or 30 mg/kg on days 0, +1, and +2 was ineffective in prolonging islet allograft survival. Wistar-Furth islets, which were UV-irradiated at 850–900 J/m2 and cultured for 24 hr prior to transplantation, did not survive any longer than those in control animals receiving untreated islets (MST 5.5 + 1 day). When UV irradiation of islets was combined with recipient peritransplant treatment with CsA at 15 mg/kg on days 0,+1, and +2 islet allograft survival was markedly prolonged (MST of 18 + 4.1 days). Treatment of diabetic recipients of UV irradiated islets with an increased dose of CsA (30 mg/kg) during the same peritransplant period (0, +1, +2 days) resulted in 100{\%} islet allograft survival beyond 120 days. This data demonstrate the effectiveness and synergism between the use of the pretransplant UV irradiation of islet allograft and the peritransplant immunosuppression of the recipient with CsA in inducing prolonged islet allograft survival in “high responder” recipients, in which the singular use of either modality may be ineffective.",
author = "Henry Lau and Keith Reemtsma and Hardy, {Mark A.}",
year = "1984",
language = "English (US)",
volume = "38",
pages = "566--569",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The use of direct ultraviolet irradiation and cyclosporine in facilitating indefinite pancreatic islet allograft acceptance

AU - Lau, Henry

AU - Reemtsma, Keith

AU - Hardy, Mark A.

PY - 1984

Y1 - 1984

N2 - We have previously shown that direct ultraviolet (UV) irradiation of islets can reduce their immunogenicity without alteration of their endocrine function and effect prolonged survival of islet allografts in the Lewis-to-ACI strain combination without the use of immuno-suppression. This study extends that work to investigate the survival of UV-irradiated Wistar-Furth islets instreptozotocin-diabetic Lewis rats, in which case the recipient is a relatively “high responder” to W/F alloantigens. Lewis recipients of 24-hr cultured W/F isletsuniformly rejected islet allografts within one week of transplantation while the additional immunosuppression with cyclosporine (CsA) at 15 or 30 mg/kg on days 0, +1, and +2 was ineffective in prolonging islet allograft survival. Wistar-Furth islets, which were UV-irradiated at 850–900 J/m2 and cultured for 24 hr prior to transplantation, did not survive any longer than those in control animals receiving untreated islets (MST 5.5 + 1 day). When UV irradiation of islets was combined with recipient peritransplant treatment with CsA at 15 mg/kg on days 0,+1, and +2 islet allograft survival was markedly prolonged (MST of 18 + 4.1 days). Treatment of diabetic recipients of UV irradiated islets with an increased dose of CsA (30 mg/kg) during the same peritransplant period (0, +1, +2 days) resulted in 100% islet allograft survival beyond 120 days. This data demonstrate the effectiveness and synergism between the use of the pretransplant UV irradiation of islet allograft and the peritransplant immunosuppression of the recipient with CsA in inducing prolonged islet allograft survival in “high responder” recipients, in which the singular use of either modality may be ineffective.

AB - We have previously shown that direct ultraviolet (UV) irradiation of islets can reduce their immunogenicity without alteration of their endocrine function and effect prolonged survival of islet allografts in the Lewis-to-ACI strain combination without the use of immuno-suppression. This study extends that work to investigate the survival of UV-irradiated Wistar-Furth islets instreptozotocin-diabetic Lewis rats, in which case the recipient is a relatively “high responder” to W/F alloantigens. Lewis recipients of 24-hr cultured W/F isletsuniformly rejected islet allografts within one week of transplantation while the additional immunosuppression with cyclosporine (CsA) at 15 or 30 mg/kg on days 0, +1, and +2 was ineffective in prolonging islet allograft survival. Wistar-Furth islets, which were UV-irradiated at 850–900 J/m2 and cultured for 24 hr prior to transplantation, did not survive any longer than those in control animals receiving untreated islets (MST 5.5 + 1 day). When UV irradiation of islets was combined with recipient peritransplant treatment with CsA at 15 mg/kg on days 0,+1, and +2 islet allograft survival was markedly prolonged (MST of 18 + 4.1 days). Treatment of diabetic recipients of UV irradiated islets with an increased dose of CsA (30 mg/kg) during the same peritransplant period (0, +1, +2 days) resulted in 100% islet allograft survival beyond 120 days. This data demonstrate the effectiveness and synergism between the use of the pretransplant UV irradiation of islet allograft and the peritransplant immunosuppression of the recipient with CsA in inducing prolonged islet allograft survival in “high responder” recipients, in which the singular use of either modality may be ineffective.

UR - http://www.scopus.com/inward/record.url?scp=0021747463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021747463&partnerID=8YFLogxK

M3 - Article

C2 - 6438844

AN - SCOPUS:0021747463

VL - 38

SP - 566

EP - 569

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -